Summit AI - The 3D AI Platform

Alpenglow Biosciences has announced Summit AI, an AI-powered platform for 3D tissue imaging and digital pathology, designed to generate quantitative readouts and spatial profiling from full biopsy data in dermatology.

The name reflects the platform’s purpose: helping teams reach a clearer, higher-level view of tissue biology from complex imaging data.

Built on a foundation-model approach and designed for volumetric imaging, Summit AI enables analysis of tissue architecture, immune organization, and structural remodeling across intact tissue samples.

The platform is initially focused on inflammatory skin disease, where full biopsy context is critical for understanding disease biology and generating comparable, quantitative tissue signatures.

Read the official press release: https://www.businesswire.com/news/home/20260505506665/en/Alpenglow-Biosciences-Introduces-Summit-AI-for-Quantitative-Analysis-of-Whole-Tissue-Imaging-in-Dermatology

Explore Summit AI

Summit AI connects AI-powered analysis with whole tissue imaging to produce structured, decision-ready outputs across research and development workflows.

Learn more about the platform, its capabilities, and applications in dermatology on the official page:

Next
Next

Alpenglow Biosciences and PathNet Form Strategic Partnership to Advance National Platform for 3D AI Cancer Diagnostics